omniture
logo
Search
A*STAR
Media Room

Latest News

rss

Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)

* EBC-129 is an antibody-drug conjugate (ADC) that selectively targets a novel, tumour-specific N...

2025-06-03 14:00 2614

Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma

* EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical developm...

2025-05-28 14:00 1935